Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25243792)

  • 1. Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer.
    Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
    PLoS One; 2014; 9(9):e108265. PubMed ID: 25243792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.
    Kim SH; Yang WI; Min YH; Ko YH; Yoon SO
    Tumour Biol; 2016 Feb; 37(2):2037-47. PubMed ID: 26337274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
    Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.
    Benard A; Goossens-Beumer IJ; van Hoesel AQ; de Graaf W; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
    BMC Cancer; 2014 Jul; 14():531. PubMed ID: 25047223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear expression of histone deacetylases and their histone modifications predicts clinical outcome in colorectal cancer.
    Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; de Graaf W; Putter H; Zeestraten EC; Liefers GJ; van de Velde CJ; Kuppen PJ
    Histopathology; 2015 Jan; 66(2):270-82. PubMed ID: 25307864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
    Cho YJ; Kim SH; Kim EK; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Jung ST; Kim HS
    BMC Cancer; 2018 Feb; 18(1):158. PubMed ID: 29415665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Chen S; Chen J; Zhan Q; Zhu Y; Chen H; Deng X; Hou Z; Shen B; Chen Y; Peng C
    Oncotarget; 2014 Nov; 5(21):10421-33. PubMed ID: 25431952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
    Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
    Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
    Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
    Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma.
    Kim SH; Kim SH; Yang WI; Kim SJ; Yoon SO
    Oncotarget; 2017 May; 8(19):31305-31317. PubMed ID: 28412742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
    Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
    Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer.
    He LJ; Cai MY; Xu GL; Li JJ; Weng ZJ; Xu DZ; Luo GY; Zhu SL; Xie D
    Asian Pac J Cancer Prev; 2012; 13(7):3173-8. PubMed ID: 22994729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
    Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
    Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation.
    Kim HG; Kim DJ; Li S; Lee KY; Li X; Bode AM; Dong Z
    J Biol Chem; 2012 Sep; 287(38):31920-8. PubMed ID: 22843710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycomb group protein expression during differentiation of human embryonic stem cells into pancreatic lineage in vitro.
    Pethe P; Nagvenkar P; Bhartiya D
    BMC Cell Biol; 2014 May; 15():18. PubMed ID: 24885493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer.
    Liu YL; Gao X; Jiang Y; Zhang G; Sun ZC; Cui BB; Yang YM
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):661-9. PubMed ID: 25326896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
    Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO
    Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.